Thank you again for joining us. This is Nihar Desai from the Yale School of Medicine, for the Medscape InDiscussion Cardiorenal Metabolic Syndrome Podcast.
Hosted on MSN2mon
New research reveals two types of fatty liver disease"One is more aggressive and mainly affects the liver, while the other is entwined in the cardio-renal-metabolic syndrome." The researchers used genetic tests to identify 27 new genetic variants ...
can we prevent the development of the visceral insulin resistance-adiposity syndrome and metabolic cardiorenal disease? Diabetes prevention or delay has been seen with tirzepatide. The future ...
In contrast to cardiorenal syndrome ... should the enhancement of cardiovascular death initiated by kidney disease be termed 'renocardiac syndrome'? As the kidney is the primary regulator of ...
E-Star BioTech, LLC (“E-Star” or the “Company”), an innovative developer of novel peptides designed to treat cardiovascular, ...
Burnett Jr., MD, Director of the Cardiorenal Research Laboratory at ... agreement for the development of MANP in cardiovascular and metabolic indications in 2021. With the support of $36 million ...
NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- E-Star BioTech, LLC (“E-Star” or the “Company”), an innovative developer of novel peptides designed to treat cardiovascular, metabolic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback